BTIG Research initiated coverage on CASI Pharma with a new price target
$CASI
Biotechnology: Pharmaceutical Preparations
Health Care
BTIG Research initiated coverage of CASI Pharma with a rating of Buy and set a new price target of $4.00
Save time and jump to the most important pieces.